| Primary |
| Fatigue |
60.0% |
| Condition Aggravated |
20.0% |
| Neoplasm Malignant |
20.0% |
|
| Angina Pectoris |
14.3% |
| Dehydration |
14.3% |
| Dizziness |
14.3% |
| Febrile Neutropenia |
14.3% |
| Medication Error |
14.3% |
| Pyrexia |
14.3% |
| Vomiting |
14.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.1% |
| Ill-defined Disorder |
14.8% |
| Product Used For Unknown Indication |
12.6% |
| Rabies |
8.2% |
| Hypertension |
7.1% |
| Arrhythmia |
2.2% |
| Atrial Fibrillation |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Blood Lactate Dehydrogenase Abnormal |
2.2% |
| Blood Pressure |
2.2% |
| Cardiac Disorder |
2.2% |
| Depression |
2.2% |
| Hiv Infection |
2.2% |
| Pain |
2.2% |
| Diabetes |
1.6% |
| Parkinson's Disease |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Arthritis |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Diabetes Mellitus |
1.1% |
|
| Prophylaxis Of Nausea And Vomiting |
10.3% |
| Haematochezia |
6.9% |
| Malaise |
6.9% |
| Mania |
6.9% |
| Rash |
6.9% |
| Rash Generalised |
6.9% |
| Supraventricular Tachycardia |
6.9% |
| Tremor |
6.9% |
| Activated Partial Thromboplastin Time Shortened |
3.4% |
| Anaemia |
3.4% |
| Disturbance In Attention |
3.4% |
| Drug Ineffective |
3.4% |
| Feeling Hot |
3.4% |
| Flatulence |
3.4% |
| Gastrointestinal Haemorrhage |
3.4% |
| Hyperkinesia |
3.4% |
| Insomnia |
3.4% |
| International Normalised Ratio Decreased |
3.4% |
| Medication Error |
3.4% |
| Melas Syndrome |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.3% |
| Drug Use For Unknown Indication |
13.3% |
| Prophylaxis |
7.2% |
| Hypertension |
6.7% |
| Blood Cholesterol Increased |
4.7% |
| Parkinson's Disease |
3.9% |
| Atrial Fibrillation |
3.7% |
| Depression |
3.2% |
| Cardiac Disorder |
2.7% |
| Pain |
2.7% |
| Supplementation Therapy |
2.7% |
| Diabetes Mellitus |
2.6% |
| Vitamin Supplementation |
2.3% |
| Nutritional Support |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Routine Health Maintenance |
1.9% |
| Multiple Sclerosis |
1.8% |
| Osteoporosis |
1.6% |
| Asthma |
1.5% |
| Rheumatoid Arthritis |
1.5% |
|
| Vomiting |
13.6% |
| Weight Increased |
11.7% |
| Myalgia |
8.9% |
| Weight Decreased |
8.9% |
| Pain |
5.6% |
| Pain In Extremity |
5.2% |
| Nausea |
4.4% |
| Flushing |
4.2% |
| Pruritus |
3.7% |
| Fatigue |
3.5% |
| Myocardial Infarction |
3.5% |
| Drug Ineffective |
3.3% |
| Tremor |
3.3% |
| Vision Blurred |
3.3% |
| Paraesthesia |
3.0% |
| Death |
2.8% |
| Somnolence |
2.8% |
| Tachycardia |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Atrial Fibrillation |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Arrhythmia |
9.5% |
| Atrial Fibrillation |
4.8% |
| Breast Cancer |
4.8% |
| Pollakiuria |
4.8% |
| Prostatic Disorder |
4.8% |
| Skin Laceration |
4.8% |
|
| Gastrointestinal Haemorrhage |
40.0% |
| Potentiating Drug Interaction |
20.0% |
| Restlessness |
20.0% |
| Supraventricular Extrasystoles |
20.0% |
|
